{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T08:40:08Z","timestamp":1746607208095,"version":"3.40.5"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T00:00:00Z","timestamp":1745884800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/deed.de"},{"start":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T00:00:00Z","timestamp":1745884800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/deed.de"}],"funder":[{"DOI":"10.13039\/501100001636","name":"University College Cork","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001636","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nervenarzt"],"published-print":{"date-parts":[[2025,5]]},"abstract":"<jats:title>Zusammenfassung<\/jats:title>\n          <jats:p>Zwischen der Aufmerksamkeitsdefizit\u2011\/Hyperaktivit\u00e4tsst\u00f6rung (ADHS) und einem erh\u00f6hten Risiko f\u00fcr kardiometabolische Erkrankungen wie Adipositas, Diabetes mellitus und arterielle Hypertonie besteht eine enge Verbindung \u00fcber die gesamte Lebensspanne. Urs\u00e4chlich sind nach heutigem Wissen genetische Faktoren, Dopaminstoffwechselst\u00f6rungen, zirkadiane Rhythmusst\u00f6rungen, Entz\u00fcndungsprozesse und nicht zuletzt ungesunder Lebensstil. Die Behandlung von Individuen mit ADHS und komorbiden kardiometabolischen Erkrankungen erfordert einen individualisierten Ansatz mit Lebensstil\u00e4nderungen, Psychotherapie und medikament\u00f6ser Therapie unter Ber\u00fccksichtigung m\u00f6glicher kardiometabolischer Nebenwirkungen der Medikamente.<\/jats:p>","DOI":"10.1007\/s00115-025-01828-4","type":"journal-article","created":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T13:28:37Z","timestamp":1745933317000},"page":"309-317","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Aufmerksamkeitsdefizit\u2011\/Hyperaktivit\u00e4tsst\u00f6rung und kardiometabolische Erkrankungen: Pr\u00e4valenz, \u00c4tiologie und Behandlung","Attention deficit\/hyperactivity disorder and cardiometabolic diseases: prevalence, etiology and treatment"],"prefix":"10.1007","volume":"96","author":[{"given":"Sarah","family":"Kittel-Schneider","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,29]]},"reference":[{"issue":"8","key":"1828_CR1","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1007\/s11892-019-1174-x","volume":"19","author":"Z Landau","year":"2019","unstructured":"Landau\u00a0Z, Pinhas-Hamiel\u00a0O (2019) Attention deficit\/hyperactivity, the metabolic syndrome, and type\u00a02 diabetes. Curr Diab Rep 19(8):46","journal-title":"Curr Diab Rep"},{"key":"1828_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-3-319-48382-5_1","volume":"960","author":"A Engin","year":"2017","unstructured":"Engin\u00a0A (2017) The definition and prevalence of obesity and metabolic syndrome. Adv Exp Med Biol 960:1\u201317","journal-title":"Adv Exp Med Biol"},{"key":"1828_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2021.10.035","author":"S Kittel-Schneider","year":"2021","unstructured":"Kittel-Schneider\u00a0S et\u00a0al (2021) Non-mental diseases associated with ADHD across the lifespan: fidgety Philipp and Pippi Longstocking at risk of multimorbidity? Neurosci Biobehav Rev. https:\/\/doi.org\/10.1016\/j.neubiorev.2021.10.035","journal-title":"Neurosci Biobehav Rev"},{"key":"1828_CR4","doi-asserted-by":"publisher","first-page":"104662","DOI":"10.1016\/j.neubiorev.2022.104662","volume":"137","author":"G Arrondo","year":"2022","unstructured":"Arrondo\u00a0G et\u00a0al (2022) Associations between mental and physical conditions in children and adolescents: an umbrella review. Neurosci Biobehav Rev 137:104662","journal-title":"Neurosci Biobehav Rev"},{"issue":"11","key":"1828_CR5","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1017\/S0033291718002532","volume":"49","author":"Q Chen","year":"2019","unstructured":"Chen\u00a0Q et\u00a0al (2019) Attention-deficit\/hyperactivity disorder and clinically diagnosed obesity in adolescence and young adulthood: a\u00a0register-based study in Sweden. Psychol Med 49(11):1841\u20131849","journal-title":"Psychol Med"},{"key":"1828_CR6","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1016\/j.neubiorev.2021.10.035","volume":"132","author":"S Kittel-Schneider","year":"2022","unstructured":"Kittel-Schneider\u00a0S et\u00a0al (2022) Non-mental diseases associated with ADHD across the lifespan: Fidgety Philipp and Pippi Longstocking at risk of multimorbidity? Neurosci Biobehav Rev 132:1157\u20131180","journal-title":"Neurosci Biobehav Rev"},{"issue":"1","key":"1828_CR7","doi-asserted-by":"publisher","first-page":"5136","DOI":"10.1038\/s41598-021-84573-3","volume":"11","author":"J Rowland","year":"2021","unstructured":"Rowland\u00a0J, Wilson\u00a0CA (2021) The association between gestational diabetes and ASD and ADHD: a\u00a0systematic review and meta-analysis. Sci Rep 11(1):5136","journal-title":"Sci Rep"},{"issue":"3","key":"1828_CR8","doi-asserted-by":"publisher","first-page":"e12158","DOI":"10.1002\/jcv2.12158","volume":"3","author":"L Li","year":"2023","unstructured":"Li\u00a0L et\u00a0al (2023) Attention-deficit\/hyperactivity disorder is associated with increased risk of cardiovascular diseases: a\u00a0systematic review and meta-analysis. JCPP Adv 3(3):e12158","journal-title":"JCPP Adv"},{"key":"1828_CR9","doi-asserted-by":"crossref","unstructured":"Krieg S et\u00a0al (2024) What is the link between attention-deficit\/hyperactivity disorder (ADHD) and Dyslipidemia in adults? A\u00a0German retrospective cohort study. J\u00a0Clin Med 13(15)","DOI":"10.3390\/jcm13154460"},{"issue":"4","key":"1828_CR10","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1192\/bjp.2023.90","volume":"223","author":"AK Thapar","year":"2023","unstructured":"Thapar\u00a0AK et\u00a0al (2023) Childhood attention-deficit hyperactivity disorder problems and mid-life cardiovascular risk: prospective population cohort study. Br J Psychiatry 223(4):472\u2013477","journal-title":"Br J Psychiatry"},{"key":"1828_CR11","doi-asserted-by":"crossref","unstructured":"Wen YC et\u00a0al (2025) Genetic evidence of the causal relationships between psychiatric disorders and cardiovascular diseases. J\u00a0Psychosom Res 189:","DOI":"10.1016\/j.jpsychores.2024.112029"},{"key":"1828_CR12","doi-asserted-by":"crossref","unstructured":"Du Rietz E et\u00a0al (2024) The contribution of attention-deficit\/hyperactivity disorder polygenic load to metabolic and cardiovascular health outcomes: a\u00a0large-scale population and sibling study. Transl Psychiatry 14(1)","DOI":"10.1038\/s41398-024-03178-2"},{"issue":"2","key":"1828_CR13","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1177\/1087054720978556","volume":"26","author":"U Bondopadhyay","year":"2022","unstructured":"Bondopadhyay\u00a0U, Diaz-Orueta\u00a0U, Coogan\u00a0AN (2022) A\u00a0systematic review of sleep and circadian rhythms in children with attention deficit hyperactivity disorder. J\u00a0Atten Disord 26(2):149\u2013224","journal-title":"J Atten Disord"},{"issue":"3","key":"1828_CR14","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1177\/1087054711428965","volume":"17","author":"D Bijlenga","year":"2013","unstructured":"Bijlenga\u00a0D et\u00a0al (2013) Associations between sleep characteristics, seasonal depressive symptoms, lifestyle, and ADHD symptoms in adults. J\u00a0Atten Disord 17(3):261\u2013275","journal-title":"J Atten Disord"},{"key":"1828_CR15","doi-asserted-by":"crossref","unstructured":"Schnorr I et\u00a0al (2024) Inflammatory biotype of ADHD is linked to chronic stress: a\u00a0data-driven analysis of the inflammatory proteome. Transl Psychiatry 14(1)","DOI":"10.1038\/s41398-023-02729-3"},{"issue":"10","key":"1828_CR16","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/j.jagp.2023.06.001","volume":"31","author":"M Ly","year":"2023","unstructured":"Ly\u00a0M et\u00a0al (2023) Neuroinflammation: a\u00a0modifiable pathway linking obesity, alzheimer\u2019s disease, and depression. Am J Geriatr Psychiatry 31(10):853\u2013866","journal-title":"Am J Geriatr Psychiatry"},{"key":"1828_CR17","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/978-981-19-7376-5_15","volume":"1411","author":"D Vazquez-Gonzalez","year":"2023","unstructured":"Vazquez-Gonzalez\u00a0D et\u00a0al (2023) A\u00a0potential role for neuroinflammation in ADHD. Adv Exp Med Biol 1411:327\u2013356","journal-title":"Adv Exp Med Biol"},{"issue":"9","key":"1828_CR18","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1515\/CCLM.2003.174","volume":"41","author":"MI Schmidt","year":"2003","unstructured":"Schmidt\u00a0MI, Duncan\u00a0BB (2003) Diabesity: an inflammatory metabolic condition. Clin Chem Lab Med 41(9):1120\u20131130","journal-title":"Clin Chem Lab Med"},{"issue":"1","key":"1828_CR19","doi-asserted-by":"publisher","first-page":"e0169277","DOI":"10.1371\/journal.pone.0169277","volume":"12","author":"LM Pelsser","year":"2017","unstructured":"Pelsser\u00a0LM et\u00a0al (2017) Diet and ADHD, reviewing the evidence: a\u00a0systematic review of meta-analyses of double-blind placebo-controlled trials evaluating the efficacy of diet interventions on the behavior of children with ADHD. Plos One 12(1):e169277","journal-title":"Plos One"},{"issue":"3","key":"1828_CR20","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1038\/npp.2017.160","volume":"43","author":"JPC Chang","year":"2018","unstructured":"Chang\u00a0JPC et\u00a0al (2018) Omega\u20113 polyunsaturated fatty acids in youths with attention deficit hyperactivity disorder: a\u00a0systematic review and meta-analysis of clinical trials and biological studies. Neuropsychopharmacology 43(3):534\u2013545","journal-title":"Neuropsychopharmacology"},{"key":"1828_CR21","doi-asserted-by":"crossref","unstructured":"Salvat H et\u00a0al (2022) Nutrient intake, dietary patterns, and anthropometric variables of children with ADHD in comparison to healthy controls: a\u00a0case-control study. BMC Pediatr 22(1)","DOI":"10.1186\/s12887-022-03123-6"},{"key":"1828_CR22","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.puhe.2024.08.029","volume":"237","author":"C Namimi-Halevi","year":"2024","unstructured":"Namimi-Halevi\u00a0C et\u00a0al (2024) Attention-deficit fi cit hyperactivity disorder is associated with risky and unhealthy behaviours among adolescents. Public Health 237:51\u201356","journal-title":"Public Health"},{"key":"1828_CR23","doi-asserted-by":"crossref","unstructured":"Kase BE et\u00a0al (2021) Longitudinal associations between symptoms of ADHD and BMI from late childhood to early adulthood. Pediatrics 147(6)","DOI":"10.1542\/peds.2020-036657"},{"key":"1828_CR24","doi-asserted-by":"publisher","DOI":"10.1177\/1087054718808045","author":"E Mellstrom","year":"2018","unstructured":"Mellstrom\u00a0E et\u00a0al (2018) Methylphenidate and reduced overweight in children with ADHD. J\u00a0Atten Disord. https:\/\/doi.org\/10.1177\/1087054718808045","journal-title":"J Atten Disord"},{"issue":"1","key":"1828_CR25","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1176\/appi.ajp.2015.15020266","volume":"173","author":"S Cortese","year":"2016","unstructured":"Cortese\u00a0S et\u00a0al (2016) Association between ADHD and obesity: a\u00a0systematic review and meta-analysis. Am J Psychiatry 173(1):34\u201343","journal-title":"Am J Psychiatry"},{"issue":"2","key":"1828_CR26","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/0006-3223(87)90223-X","volume":"22","author":"LJ Porrino","year":"1987","unstructured":"Porrino\u00a0LJ, Lucignani\u00a0G (1987) Different patterns of local brain energy metabolism associated with high and low doses of methylphenidate. Relevance to its action in hyperactive children. Biol Psychiatry 22(2):126\u2013138","journal-title":"Biol Psychiatry"},{"key":"1828_CR27","doi-asserted-by":"crossref","unstructured":"Liang EF et\u00a0al (2018) The effect of methylphenidate and atomoxetine on heart rate and systolic blood pressure in young people and adults with attention-deficit hyperactivity disorder (ADHD): systematic review, meta-analysis, and Meta-regression. Int J Environ Res Public Health 15(8)","DOI":"10.3390\/ijerph15081789"},{"issue":"6","key":"1828_CR28","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.euroneuro.2012.06.011","volume":"23","author":"E Mick","year":"2013","unstructured":"Mick\u00a0E, McManus\u00a0DD, Goldberg\u00a0RJ (2013) Meta-analysis of increased heart rate and blood pressure associated with CNS stimulant treatment of ADHD in adults. Eur Neuropsychopharmacol 23(6):534\u2013541","journal-title":"Eur Neuropsychopharmacol"},{"issue":"7","key":"1828_CR29","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1016\/j.jacc.2020.05.081","volume":"76","author":"N Torres-Acosta","year":"2020","unstructured":"Torres-Acosta\u00a0N et\u00a0al (2020) Cardiovascular effects of ADHD therapies: JACC review topic of the week. J\u00a0Am Coll Cardiol 76(7):858\u2013866","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"1828_CR30","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1586\/14737175.2015.1028370","volume":"15","author":"R Rizzo","year":"2015","unstructured":"Rizzo\u00a0R, Martino\u00a0D (2015) Guanfacine for the treatment of attention deficit hyperactivity disorder in children and adolescents. Expert Rev Neurother 15(4):347\u2013354","journal-title":"Expert Rev Neurother"},{"issue":"2","key":"1828_CR31","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1177\/2042018816638050","volume":"7","author":"M May","year":"2016","unstructured":"May\u00a0M, Schindler\u00a0C (2016) Clinically and pharmacologically relevant interactions of antidiabetic drugs. Ther Adv Endocrinol Metab 7(2):69\u201383","journal-title":"Ther Adv Endocrinol Metab"},{"key":"1828_CR32","doi-asserted-by":"publisher","first-page":"109816","DOI":"10.1016\/j.jpsychores.2019.109816","volume":"126","author":"J Macek","year":"2019","unstructured":"Macek\u00a0J et\u00a0al (2019) Impact of attention deficit hyperactivity disorder on metabolic control in adolescents with type\u00a01 diabetes. J\u00a0Psychosom Res 126:109816","journal-title":"J Psychosom Res"},{"issue":"4","key":"1828_CR33","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1177\/10870547211003659","volume":"26","author":"E Merzon","year":"2022","unstructured":"Merzon\u00a0E et\u00a0al (2022) The Association between ADHD and the Severity of COVID-19 Infection. J\u00a0Atten Disord 26(4):491\u2013501","journal-title":"J Atten Disord"},{"issue":"3","key":"1828_CR34","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1007\/s00246-012-0162-6","volume":"33","author":"AS Batra","year":"2012","unstructured":"Batra\u00a0AS, Alexander\u00a0ME, Silka\u00a0MJ (2012) Attention-deficit\/hyperactivity disorder, stimulant therapy, and the patient with congenital heart disease: evidence and reason. Pediatr Cardiol 33(3):394\u2013401","journal-title":"Pediatr Cardiol"},{"key":"1828_CR35","doi-asserted-by":"publisher","DOI":"10.1007\/s00115-020-00904-1","author":"A Hage","year":"2020","unstructured":"Hage\u00a0A et\u00a0al (2020) [Attention deficit hyperactivity disorder in childhood and adolescence : Current state of research]. Nervenarzt. https:\/\/doi.org\/10.1007\/s00115-020-00904-1","journal-title":"Nervenarzt"}],"container-title":["Der Nervenarzt"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-025-01828-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00115-025-01828-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-025-01828-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T08:21:08Z","timestamp":1746606068000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00115-025-01828-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,29]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["1828"],"URL":"https:\/\/doi.org\/10.1007\/s00115-025-01828-4","relation":{},"ISSN":["0028-2804","1433-0407"],"issn-type":[{"type":"print","value":"0028-2804"},{"type":"electronic","value":"1433-0407"}],"subject":[],"published":{"date-parts":[[2025,4,29]]},"assertion":[{"value":"19 March 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"Gem\u00e4\u00df den Richtlinien des Springer Medizin Verlags werden Autorinnen und Autoren sowie die Wissenschaftliche Leitung im Rahmen der Manuskripterstellung und Manuskriptfreigabe aufgefordert, eine vollst\u00e4ndige Erkl\u00e4rung zu ihren finanziellen und nichtfinanziellen Interessen abzugeben.\nAutorinnen und Autoren. S. Kittel-Schneider: A. Finanzielle Interessen: 08\/2021-02\/2023: Die m\u00f6glichen Auswirkungen von Omega-3-Fetts\u00e4uren mit und ohne Methylphenidat bei ADHS | Neurale Stammzellen von Patienten - Wnt-Aktivierung?, PI Edna Gr\u00fcnblatt, Co-PI Sarah Kittel-Schneider | Die Waterloo-Stiftung 56.308 \u00a3 (Verbrauchsmaterial) = 67.068,46\u20ac; Betrag f\u00fcr Co-PI: 3000 \u20ac | 03\/2022-02\/2025: Untersuchung der mitochondrialen Funktion bei PARK2 CNV-Tr\u00e4gern mit ADHS bei Erwachsenen, PIs Sarah Kittel-Schneider und Antje Appelt-Menzel | Interdisziplin\u00e4res Zentrum f\u00fcr Klinische Forschung der Medizinischen Fakult\u00e4t der Universit\u00e4t W\u00fcrzburg (IZKF), Projekt N-440 Insgesamt 330.000 \u20ac (2 Doktorandenstellen, 15.000\u20ac Verbrauchsmaterialien\/Jahr und 12.390\u20ac Sequenzierungskosten) | Betrag f\u00fcr SKS: 165.000 \u20ac | 02\/2022-05\/2025: Definition der kulturellen Heterogenit\u00e4t in hiPSC-abgeleiteten kortikalen N\u20acn Modellen neuropsychiatrischer Erkrankungen, PI Sarah Kittel-Schneider, Co-PIs Rhiannon McNeill und Franziska Radtke | Strategische F\u00f6rderung von Projekten zwischen der Universit\u00e4t W\u00fcrzburg (JMU), dem | 01\/2022-10\/2022: Universit\u00e4tsklinikum W\u00fcrzburg (UKW), dem Helmholtz-Institut f\u00fcr RNA-basierte Infektionsforschung (HIRI), dem Fraunhofer Translationszentrum Regenerative Therapien (TLZ-RT) und der Max Planck-Forschungsgruppe Systemimmunologie (W\u00dcSI) im Rahmen des neuen Einzelzellzentrums W\u00fcrzburg 8000\u20ac (Verbrauchsmaterial f\u00fcr die RNA-Einzelzellsequenzierung) 02\/2022-05\/2025: Baby-Lotsenprojekt, PI Sarah Kittel-Schneider, Co-PI Ursula Berninger | Deutsches Hilfswerk, SeeYou Stiftung, Lion`s Club (W\u00fcrzburg) Nr. 20210452 190.000\u20ac (2 Sozialarbeiter und Verbrauchsmaterial) | 08\/2023-31\/12\/2026: UplusE: App-basiertes Screening auf perinatale Depression, Bindungsschwierigkeiten und psychosoziale Risikofaktoren bei Eltern durch Anbieter von Kindergesundheitsdiensten, PI Susanne Simen, Co-PI Sarah Kittel-Schneider | G-BA Innovationsfond Nr. 02NVF22115 Gesamtmittelausstattung: 4,623,480 \u20ac\/Betrag f\u00fcr SKS: 377.789,80 \u20ac (90% E13-Stelle, Verbrauchsmaterial) | 03\/2023: VBS- und MAMBA-Pilotstudien, PI Sarah Kittel-Schneider, Unibund W\u00fcrzburg, AZ 21-14 und 23-03, 4300 \u20ac (Verbrauchsmaterial) | 02\/2024-07\/2026: PeriPsych: Erstellung einer S3-Leitlinie f\u00fcr perinatale psychische St\u00f6rungen, PI Kerstin Weidner, Co-PI Sarah Kittel-Schneider G-BA Innovationsfond Nr. 01VSF23006 Finanzierung insgesamt: 323,945 \u20ac\/Betrag f\u00fcr SKS: 126.381,25 \u20ac (45% E13-Position, Verbrauchsmaterial) | 07\/2023-10\/2023: Koordinator unterst\u00fctzt PEGASOS (Plattform f\u00fcr die Integration von aus menschlichen Stammzellen gewonnenen Daten zur pr\u00e4zisen Behandlung von psychischen St\u00f6rungen) Vorschlag EU-Horizont FP7 unterst\u00fctzt, Enterprise Ireland CS20231782 12.414 \u20ac, 4.507 \u20ac f\u00fcr die 1st Stufe der Einreichung | 01\/2025-12\/2027: ADAPT-Studie - Verbesserung der ADHS-Kernsymptome und der individuellen Lebensqualit\u00e4t durch di\u00e4tetische Ans\u00e4tze \u00fcber Mikrobiota-Darm-Gehirn-Signal\u00fcbertragung, Finanzierung durch Philanthropie 1.500.000 \u20ac, PI zusammen mit John Cryan | 2024\/2025: Intramurale Infrastrukturf\u00f6rderung des University College Cork, Konfokokales Mikroskop, Gesamtsumme 500.000 Euro, Lead PI Dr Katja Burk, Co-PI Sarah Kittel-Schneider mit 100.000 \u20ac Beteiligung, | 2024\/2025: Intramurale F\u00f6rderung des College of Medicine and Health f\u00fcr ein Pilortprojekt zur Erforschung biologischer Mechanismen der Postpartum Depression, PI Dr Rachel Maloney, Co-PI Sarah Kittel-Schneider, 30.000 \u20ac. \u2013 2020 bis andauernd: DGPPN Congress, Workshop and State of the Art Symposium on Mental Illness in Pregnancy and Lactation Berlin, Germany, jeweils Honorar von der DGPPN | 11\/2020 Growing up with ADHD \u2013 challenges and issues, recorded on the 22 October 2020 for the virtual Meeting of Minds, Honorar von Takeda | 12.01.2022 Further education event Spektrum ADHS Frankfurt, University Hospital Frankfurt, Germany, Parental ADHD in peripartal period and early childhood Honorar von Universit\u00e4t Frankfurt | 08.4.2022 Online qualification seminar \u201eNachteilsausgleich f\u00fcr das Studium\u201c, Deutsches Studentenwerk, ADHD in students., Honorar vom Deutsches Studentenwerk | 12.05.2022 Hemera Clinic, Bad Kissingen, Germany, further education lecture ADHD in girls and women , Honorar von Hemera Klinik | 14.09.2022 Further education Psychiatry, Department of Psychotherapy and Psychosomatics, Ansbach District Hospital, Ansbach, Germany, Peripartum mental illnesses in mothers and fathers, Honorar vom Bezirkskrankenhaus Ansbach | 8.10.2022 Online Symposium, Psychiatrie Baselland, Switzerland, Risk factors and treatment of peripartal psychoses. Honorar von Psychiatrie Baselland, Switzerland | 12\/2022 Referenten-\/Autorent\u00e4tigkeit im Rahmen der Fort- und Weiterbildungsmodulen in der \u201cPeripartal Psychiatrie\u201d als Weiterentwicklung des E-Learning-Fortbildungsprogramms Kinderschutz, erstellt im Rahmen des Gesamtkonzepts Kinderschutz des Bayerischen Staatsministeriums f\u00fcr Familie, Arbeit und Soziales, Honorar durch Monks GmbH | 01\/2023 Referentent\u00e4tigkeit im Rahmen der Mittwochsfortbildung \u201eFr\u00fcherkennung und Fr\u00fchintervention psychischer Erkrankungen\u201c am BKH Lohr. Honorar BKH Lohr | 03\/2023 Referentent\u00e4tigkeit im Rahmen der Mittwochsfortbildung \u201ePsychische Erkrankungen bei M\u00fcttern und V\u00e4tern in Schwangerschaft und Stillzeit\u201c am Klinikum am Weissenhof, Weinsberg, Honorar vom Klinikum am Weissenhof | 09\/2023 Vortrag am Deutschen Still- und Laktationskongress, Honorar Still -und Laktationskongress | 10\/2023 Vortrag Fortbildung Klinikum Esslingen, Honorar Janssen-Cilag | 11\/07\/2024 \u00a0 \u00a0Mutter im Chaos: ADHS bei M\u00fcttern in Schwangerschaft und Stillzeit \u00a0 \u00a0Midwives of Switzerland; Workshop \u00a0 \u00a0Invited speaker Online Only, Honorar Hebammenverband Schweiz | 2024 Gutachtert\u00e4tigkeit \u00fcber die Fort- und Weiterbildungsmodule \u201cUPlusE: Screening und Fr\u00fchintervention peripartaler psychischer Erkrankungen und psychosozialer Belastungen | . \u2013 2021 Consultant for the PPD & MDD Insights Interview on November 30, 2021, Honorar von Biogene | 12\/2022 Review Board Wellcome Trust, Honorar vom Wellcome Trust UK | 2023 und 2024 External Reviewer f\u00fcr Chair Positions im INSERM | 2024 Gutachtert\u00e4tigkeit \u00fcber die Fort- und Weiterbildungsmodule \u201cUPlusE: Screening und Fr\u00fchintervention peripartaler psychischer Erkrankungen und psychosozialer Belastungen, Honorar von Firma Monks . \u2013 B. Nichtfinanzielle Interessen: Berufliche T\u00e4tigkeit: | Seit 06\/2023 Lehrstuhlinhaberin f\u00fcr Psychiatrie, Department of Psychiatry and Neurobehavioural Science, University College Cork\/Consultant f\u00fcr allgemeine Erwachsenenpsychiatrie, South Lee Mental Health Service, Universit\u00e4tsklinikum Cork, Cork, Irland | 07\/2019\u201305\/2023 Stellvertretende Direktorin, Abteilung f\u00fcr Psychiatrie, Psychosomatische Medizin und Psychotherapie, Universit\u00e4tsklinikum W\u00fcrzburg, W\u00fcrzburg, Deutschland und W2-Professor f\u00fcr Entwicklungspsychiatrie, Leiterin der Abteilungen f\u00fcr Transitionspsychiatrie und Peripartale Psychiatrie | | Aktive Mitgliedschaften: International Marc\u00e9 Society for Psychiatric Disorders of Childbearing (Stellvertretende Vorsitzende deutsche Sektion seit 05\/2023, Vorstandsmitglied International Marc\u00e9-Society 5\/2020 und gew\u00e4hlte Schatzmeisterin 06\/2024), Leiterin Referat Forschung und internationale Beziehungen der DGBS 01\/2021 \u2013 09\/2024, Co-Chair des ECNP Network iPSC platform for Neuropsychiatry seit 10\/2022, Leiterin der WG3 der EU Cost Action CA22114 - Maternal Perinatal Stress and Adverse Outcomes in the Offspring: Maximising infants\u00b4development (TREASURE); Sprecherin des B\u00fcndnis gegen Depression W\u00fcrzburg 02\/2020-02\/2023, WG1 und Guidelines Group EU COST Action CA18138 RISEUP PPD 2020-2023; DFG Netzwerk Bridging the gap: Integrating research on personality and perinatal mental health, Psychiatric Genetic Consortium (PGC) ADHD and Bipolar working group; IMpACT consortium; ConLiGen consortium; ECNP network ADHD over the lifespan | Weitere Mitgliedschaften World Federation of ADHD, Eunethydis, DGPPN, DGBP, Schatten und Licht e.V., Hospizverein W\u00fcrzburg, DHV, D\u00c4VT | Trustee Board Member Samaritans Cork, seit Januar 2025.\nWissenschaftliche Leitung. Die vollst\u00e4ndige Erkl\u00e4rung zum Interessenkonflikt der Wissenschaftlichen Leitung finden Sie am Kurs der zertifizierten Fortbildung auf www.springermedizin.de\/cme.\nDer Verlag erkl\u00e4rt, dass f\u00fcr die Publikation dieser CME-Fortbildung keine Sponsorengelder an den Verlag flie\u00dfen.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"S.\u00a0Kittel-Schneider hat in den letzten 5\u00a0Jahren Honorare f\u00fcr Vortr\u00e4ge von Takeda, Medice Arzneimittel P\u00fctter GmbH & Co KG und Janssen erhalten.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Autoren"}},{"value":"Die vollst\u00e4ndige Erkl\u00e4rung zum Interessenkonflikt der Wissenschaftlichen Leitung finden Sie am Kurs der zertifizierten Fortbildung auf .","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Wissenschaftliche Leitung"}},{"value":"erkl\u00e4rt, dass f\u00fcr die Publikation dieser CME-Fortbildung keine Sponsorengelder an den Verlag flie\u00dfen.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}}]}}